American International Group’s Quince Therapeutics QNCX Stock Holding History

American International Group’s Portfolio QNCX Stock Details QNCX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-50	Closed	-$61K	–	3232
2022 Q1	$61K	Sell	50 -3	-6%	-$4.08K	﹤0.01%	2781
2021 Q4	$134K	Sell	53 -2	-4%	-$12.2K	﹤0.01%	2592
2021 Q3	$1M	Sell	55 -1	-2%	-$15.9K	0.01%	1447
2021 Q2	$592	Buy	56 +10	+22%	+$83.9K	﹤0.01%	1813
2021 Q1	$330	Hold	46	–	–	﹤0.01%	2075
2020 Q4	$254	Sell	46 -1	-2%	-$8.86K	﹤0.01%	2153
2020 Q3	$470K	Sell	47 -1	-2%	-$9.1K	﹤0.01%	1620
2020 Q2	$445K	Buy	48 +14	+41%	+$128K	﹤0.01%	1659
2020 Q1	$307K	Sell	34 -2	-6%	-$19.7K	﹤0.01%	1671
2019 Q4	$400K	Buy	36 +27	+300%	+$163K	﹤0.01%	1823
2019 Q3	$47K	Hold	9	–	–	﹤0.01%	2899
2019 Q2	$78K	Buy	+9	New	+$53.8K	﹤0.01%	2802

Other funds holding QNCX

ECG

EPIQ Capital Group San Francisco, California $383M AUM 46.87% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

PHAM

Pacific Heights Asset Management San Francisco, California $2.99B AUM 52.5% 1-Year Est. Return

American International Group's QNCX Position: Q2 2022 in Review

American International Group sold out of Quince Therapeutics (QNCX) in Q2 2022, closing a stake of 50 shares — an estimated $61K sold.

American International Group first reported a position in QNCX in Q2 2019 and held it in 12 quarters. The position peaked at $1M in Q3 2021. 66 funds tracked by Wall St. Rank hold QNCX as of Q2 2022.

American International Group reported no remaining Quince Therapeutics position as of Q2 2022 after selling out during the quarter.
American International Group sold 50 Quince Therapeutics shares in Q2 2022, an estimated $61K.
American International Group first reported a position in Quince Therapeutics in Q2 2019 and held it in 12 quarters.
American International Group's Quince Therapeutics position peaked at $1M in Q3 2021.
66 funds tracked by Wall St. Rank held Quince Therapeutics as of Q2 2022.

Based on American International Group's 13F filing for Q2 2022, filed 12 Aug 2022.